Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
 

Learn about the flu shot, COVID-19 vaccine, and our masking policy »

Stanford Health Care

Platelet-rich Plasma in Orthopaedic Applications: Evidence-based Recommendations for Treatment JOURNAL OF THE AMERICAN ACADEMY OF ORTHOPAEDIC SURGEONS Hsu, W. K., Mishra, A., Rodeo, S. R., Fu, F., Terry, M. A., Randelli, P., Canale, S. T., Kelly, F. B. 2013; 21 (12): 739-748

Abstract

Autologous platelet-rich plasma (PRP) therapies have seen a dramatic increase in breadth and frequency of use for orthopaedic conditions in the past 5 years. Rich in many growth factors that have important implications in healing, PRP can potentially regenerate tissue via multiple mechanisms. Proposed clinical and surgical applications include spinal fusion, chondropathy, knee osteoarthritis, tendinopathy, acute and chronic soft-tissue injuries, enhancement of healing after ligament reconstruction, and muscle strains. However, for many conditions, there is limited reliable clinical evidence to guide the use of PRP. Furthermore, classification systems and identification of differences among products are needed to understand the implications of variability.

View details for DOI 10.5435/JAAOS-21-12-739

View details for Web of Science ID 000329011700004

View details for PubMedID 24292930